跳至主要内容
临床试验/JPRN-UMIN000005174
JPRN-UMIN000005174已完成未知

A safety and efficacy study of autologous bone marrow cell transplantation for HIV positive patients with cirrhosis - ABMi liver regeneration project

ational Center for Global Health and Medicine0 个研究点目标入组 10 人开始时间: 2011年3月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Cases applicable to ANY condition of the following: 1) Hepatocellular carcinoma (HCC), except for cases having been treated completely without history of recurrence 2) Malignant tumor other than HCC 3) Alcoholic liver disease (ALD) 4) Hemoglobin under 8g/dL or Platelets under 20/ml at the registration 5) Esophageal or gastric varices with a risk of bursting, except for cases only with cured history of such conditions 6) Cases that cannot obtain the informed consent to autologous blood transfusion 7) Pregnancy 8) Renal dysfunction with 2mg/dL or higher serum creatinine 9) Performance Status 3 or 4 (assessment excludes hemophilic arthritis related daily life limitations) 10) not fit for general anesthesia 11) other conditions that doctor considered not suitable for the study

研究者

发起方
ational Center for Global Health and Medicine

相似试验